É-Conotoxins GVIA, MVIIA and CVID: SAR and Clinical Potential
Abstract: Highly selective N-type voltage-gated calcium (CaV) channel inhibitors from cone snail venom (the É-conotoxins) have emerged as a new class of therapeutics for the treatment of chronic and neuropathic pain. Earlier in 2005, Prialt (Elan) or synthetic É-conotoxin MVIIA, was the first ÃÂ...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2006-04-01
|
| Series: | Marine Drugs |
| Subjects: | |
| Online Access: | http://www.mdpi.com/1660-3397/4/3/193/ |